ArticleVaccine2009

A live attenuated H7N3 influenza virus vaccine is well tolerated and immunogenic in a Phase I trial in healthy adults.

Kawsar R Talaat et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.